Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

Off-target toxicity due to the expression of target antigens in normal tissue or TCR cross-reactivity represents a major risk when using T cell receptor (TCR)-engineered T cells for treatment of solid tumours. Due to the inherent cross-reactivity of TCRs it is difficult to accurately predict their t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mensali, Nadia, Myhre, Marit Renée, Dillard, Pierre, Pollmann, Sylvie, Gaudernack, Gustav, Kvalheim, Gunnar, Wälchli, Sébastien, Inderberg, Else Marit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682583/
https://www.ncbi.nlm.nih.gov/pubmed/31214732
http://dx.doi.org/10.1007/s00262-019-02356-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682583/
https://www.ncbi.nlm.nih.gov/pubmed/31214732
http://dx.doi.org/10.1007/s00262-019-02356-2

Ejemplares similares